Spain Pharma News Roundup September 2020
A roundup of the latest news from Spanish pharma, including J&J’s COVID-19 vaccine trial, the latest developments at Spanish firm PharmaMar…
Tagged with Spain
Spain’s PharmaMar to Begin COVID-19 Trials for Aplidin
PharmaMar, a Spanish firm, is beginning Phase II clinical trials for its anti-tumour drug Aplidin to treat coronavirus. The firm’s stocks have…
Ian Wilders – Managing Director, Labo’Life, Belgium
Ian Wilders of Spain-headquartered micro-immunotherapy specialist Labo’Life discusses the strategic importance of Belgium to the company as the…
Most Looked at Countries in 2019
PharmaBoardroom had the opportunity to sit down with over six hundred key stakeholders in the life sciences industry across fifteen different…
New Spain Pharma Report September 2019 Out Now
Building on the topics covered in our March 2019 report, the latest edition of Healthcare & Life Sciences Review Spain takes a closer look at the…
Spain Pharma Production Snapshot
Spain’s pharma production experienced steady growth between 2011 and 2017 except for a dip in 2014 which it bounced back from in just one year,…
Spain Medtech Snapshot
Spain’s medtech imports have nearly doubled compared to its exports over the last four years. Overall the market has experienced steady growth.…
Juan Carlos Moro Rodríguez – CEO Iberia Cluster, DB…
Juan Carlos Moro Rodríguez, CEO for the Iberia Cluster with DB Schenker, discusses the company’s plans to expand its reach across all forms of…
Jazz Pharmaceuticals Spain: Playing to a Different Beat
Though still one of the younger and lesser-known outfits inhabiting the European drug development landscape, Irish-headquartered rare disease…
Specialising to Succeed in the Spanish Women’s Health Market
In what is a highly competitive and crowded women’s health field in Spain, smaller players are having to be increasingly focused and specialised to…
Philanthropy Boosts Spain’s Out-of-Date Hospital Equipment
Many of the world’s mega-rich are increasingly active philanthropists in the healthcare arena and Spain is no exception with Galician billionaire…
Aspen Spain: Thriving on Change
The global acquisition of GSK’s thrombosis portfolio and subsequent purchase of AstraZeneca’s anaesthesia business have been critical milestones…
